TARGET MedTec is actively creating value for investors

 

The long-term success of an investment company is largely dependent on the performance of the company's management. The selection of investments and the long-term and coherent strategy of such a company determine the investment result in the future. In particular, supporting companies such as Target MedTec GmbH and its supporting sister company MORPHOSE GmbH are very promising in that they significantly mentor and closely supervise the MedTech start-up companies.

​

​

 Disruptive business models

 

Instead of a fast exit strategy the focus is now back on financing disruptive business models, hard work and long-term success. It is a challenging time for all stakeholders, but a time that continues to offer opportunities. Access to the best founders and MedTech start-ups is crucial. Often, there are only one or two investments that carry the entire investment volume. This means that it is often only one or two start-ups that develop so strongly that the invested capital is multiplied. To identify companies with this kind of potential early on, management teams need a lot of experience and a large network. This is not just about financial support, but also about the fund manager's expertise and contacts.

 

 

​

Access to interesting markets 

 

Specialized companies such as Target MedTec GmbH offer investors special access to particular industries sectors (medical technology). The knowledge and focus on a special field in asset management opens up interesting business potential. The costs of entering one of the interesting segments are low for investors compared to so-called private equity investments. The investor buys indirectly through shares in the holding company, without high commission charges for the various investments. This usually offers the investor (shareholder) excellent prerequisites to purchase cost-effective expertise and promising management services through investment companies. 

​

 

.

​

​